ArticleDigestive diseases and sciences2026
Forward- vs. Oblique-Viewing Endoscope for Duodenal Papillectomy: A Comparative Study on Efficacy and Safety.
Article in Digestive diseases and sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimEndoscopic papillectomy is an effective approach for selected papillary lesions. However, no consensus on the optimal choice of endoscope for the operation. Here we conducted a comparative study to investigate the effect of forward-viewing endoscopes (FVE) and oblique-viewing endoscopes (OVE) in the efficacy and safety of endoscopic papillectomy.
methodsPatients who underwent endoscopic papillectomy with OVE and FVE between February 2019 and August 2025 were reviewed retrospectively, regardless of histopathological type. Demographic characteristics, procedure-related results, adverse events, and follow-up outcomes were analyzed. Univariate and multivariate analyses were conducted to identify the risk factors of piecemeal resection and adverse events.
resultsA total of 125 patients were included, with 65 patients in the FVE group and 60 patients in the OVE group specifically. Baseline characteristics was comparable between the two groups. The OVE-based papillectomy had a longer procedure time (21 vs. 39 min; p = 0.001), and a higher en bloc resection rate (61.5% vs. 80%; p = 0.024). After adjustment by propensity score matching (PSM), OVE remained associated with a higher en bloc resection rate (P < 0.05). No statistical significance was found in the histopathology, postoperative hospitalization, adverse events and follow-up outcomes. Further logistic regression analysis indicated that submucosal injection was the only risk factor for piecemeal resection, and no statistically significant factor was found to be related to adverse events.
conclusionsCompared with FVE, OVE tends to yield a higher en bloc resection rate for endoscopic papillectomy, and both modalities demonstrate similar safety outcomes. Submucosal injection was suggested to be a risk factor affecting en bloc resection.
Indexed as
Identifiers
42627604What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.